Skip to content

Clinical trials

Mental Disorders trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Bulgaria Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20141
20181
20201
20225
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
MapLight Therapeutics2
Pfizer2
Emalex Biosciences Inc.1
Neurocrine Biosciences1
Semmelweis University1
The National Center for Public Health and Analyzes, Bulgaria1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders14
Nervous System Diseases5
Schizophrenia Spectrum and Other Psychotic Disorders5
Alzheimer Disease4
Dementia4
Schizophrenia4
Brain Diseases3
Central Nervous System Diseases3
Neurodegenerative Diseases3
Cognitive Dysfunction2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.